Pulsenmore CEO Dr. Elazar Sonnenschein said, ‘Our device has been approved in the 510k de novo pathway. This means that there ...

Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug ...

Pulsenmore’s FDA-approved home ultrasound device allows pregnant women to perform scans from home, revolutionizing pregnancy ...

Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.

Based on these scans, clinicians are able to assess fetal heartbeat, fetal movements, and amniotic fluid volume.

Sustained acoustic medicine from ZetrOZ Systems supports recovery when players face intense physical demands, such as an ...

AI and capacitive micromachined ultrasonic transducer chips are making diagnostics faster and more accessible.

The Pulsenmore ES integrates at-home ultrasound imaging into physician-led prenatal care. The Pulsenmore cradle connects to the patient's smartphone and guides her step-by-step vi ...

Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) ...

Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman emerged with vastly improved symptoms of the Parkinson's disease that had ...

Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE ...